EPIC: At the forefront of biomedical research on eukaryotic pathogens

EPIC: At the forefront of biomedical research on eukaryotic pathogens

epic home pic

Eukaryotic pathogens cause some of the most devastating and intractable diseases in humans, including malaria, amoebic dysentery, sleeping sickness, Chagas disease and fungal meningitis. Globalization has increased such infections in the U.S. Many eukaryotic pathogens are classified as bioterrorism agents and/or neglected tropical diseases.

Clemson University’s Eukaryotic Pathogens Innovation Center — EPIC — is an interdisciplinary research cooperative founded in 2013 that is at the forefront of biomedical research on these devastating pathogens.

EPIC scientists have a lengthy track record of major contributions in this globally important area of research.


EPIC Welcomes Dr. Stephen Dolan

EPIC is excited to announce that Dr. Stephen Dolan will be joining the Center and the Department of Genetics and Biochemistry in Fall 2023 as an Assistant Professor. Dr. Dolan’s research focuses on resolving the molecular mechanisms that dictate interkingdom interaction in polymicrobial infections. Welcome to Clemson, Dr. Dolan!


Congratulations to EPIC students Jillian Milanes, Erin Jones, and Danielle LaVigne on their College of Science awards!



Congratulations to Dr. Kim Paul on the publishing of her article about Guinea worms in The Conversation!

Read the article here: https://theconversation.com/guinea-worm-a-nasty-parasite-is-nearly-eradicated-but-the-push-for-zero-cases-will-require-patience-199156


Congratulations to Dr. Jim Morris on his recent grant!

Dr. Jim Morris received a two year NIH award of $419k, which will support the development of genetic tools to study the brain-eating amoebae.

Project Name: Approaches for genetic manipulation of Naegleria fowleri

Project Number: NIH R21AI175463



For further information about the EPIC please contact us.

864-656-EPIC or clemson_epic@clemson.edu